CCL22

CCL22 Informations sur la molécule

Nom anglais	ATP Binding Cassette Subfamily D Member 1	Nombre de médicaments commercialisés	1
Nombre de médicaments cliniques	2	Alias de la cible	ATP Binding Cassette Subfamily D Member 1，Adrenoleukodystrophy Protein，ATP-Binding Cassette Sub-Family D Member 1，ALDP，ATP-Binding Cassette， Sub-Family D (ALD)， Member 1，ABC42，ABCD1，AMN，ALD，ATP Binding Cassette Transporter， Subfamily D， Member 1，Adrenoleukodystrophy
Phase de R&D la plus avancée	Approved

Nom anglais	ATP Binding Cassette Subfamily D Member 1
Alias de la cible	ATP Binding Cassette Subfamily D Member 1，Adrenoleukodystrophy Protein，ATP-Binding Cassette Sub-Family D Member 1，ALDP，ATP-Binding Cassette， Sub-Family D (ALD)， Member 1，ABC42，ABCD1，AMN，ALD，ATP Binding Cassette Transporter， Subfamily D， Member 1，Adrenoleukodystrophy
Nombre de médicaments commercialisés	1
Nombre de médicaments cliniques	2
Phase de R&D la plus avancée	Approved

CCL22 Liste de produits

Attribut
Protein (1)
Bibliothèque de produits
En ligne (1)
Espèces
Human (1)
Étiquette
Fc Tag (1)
Marqueur
Unconjugated (1)

Numéro de produit	Espèces	Système d'expression	Description du produit	Structure protéique	Pureté	Caractéristiques	Pré-commande/Commande
CC2-H5257	Human	HEK293	Human CCL22 / MDC Protein, Fc Tag				Ajouter au panier

Quantité totale1

CCL22Contexte de la molécule

This antimicrobial gene is one of several Cys-Cys (CC) cytokine genes clustered on the q arm of chromosome 16. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for monocytes, dendritic cells, natural killer cells and for chronically activated T lymphocytes. It also displays a mild activity for primary activated T lymphocytes and has no chemoattractant activity for neutrophils, eosinophils and resting T lymphocytes. The product of this gene binds to chemokine receptor CCR4. This chemokine may play a role in the trafficking of activated T lymphocytes to inflammatory sites and other aspects of activated T lymphocyte physiology.

CCL22Alias de la molécule

MDC,ABCD-1,SCYA22,STCP-1,DC,B-CK,A-152E5.1

Informations sur les médicaments cliniques

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Indication	Essai clinique
Pozetaldogene ormesparvovec	SBT-101	Phase 2 Clinical	SwanBio Therapeutics Ltd	Pheochromocytoma; Adrenoleukodystrophy	Details
TYF-ABCD1	TYF-ABCD1	Clinical	Shenzhen Geno-Immune Medical Institute	Adrenoleukodystrophy	Details

Informations sur les médicaments commercialisés

Nom anglais	Code de recherche	Phase de R&D	Entreprise	Plus ancien nom de marque	Pays d'approbation le plus ancien	Indication la plus ancienne	Société d'approbation la plus ancienne	Date d'approbation la plus ancienne	Indication	Essai clinique
Elivaldogene autotemcel		Approved	Bluebird Bio Inc, Inserm	Lenti-D, Skysona	United States	Adrenoleukodystrophy	Bluebird Bio Inc	2021-07-27	Adrenoleukodystrophy	Details